Lataa...
Apolipoprotein Measurements: Is More Widespread Use Clinically Indicated?
Apolipoprotein (apo) B may be a more sensitive measure of atherogenicity than low‐density lipoprotein cholesterol (LDL‐C) and a better index for assessing cardiovascular risk. The refined risk assessment provided by apo B may be important in patients at high cardiometabolic risk such as those with d...
Tallennettuna:
| Julkaisussa: | Clin Cardiol |
|---|---|
| Päätekijä: | |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Wiley Periodicals, Inc.
2009
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6653425/ https://ncbi.nlm.nih.gov/pubmed/19743499 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.20559 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|